Literature DB >> 30144933

Secukinumab for pyoderma gangrenosum: A case report.

María Moreno García1, Marta Madrid González2, Jesús María Prada Lobato2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30144933     DOI： 10.1016/j.medcli.2018.06.011

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  2 in total

Review 1.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

2.  Pyoderma gangrenosum treated with secukinumab: A case report.

Authors:  Meghan L McPhie; Mark G Kirchhof
Journal:  SAGE Open Med Case Rep       Date:  2020-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.